Original language | English |
---|---|
Article number | e70052 |
Number of pages | 5 |
Journal | HemaSphere |
Volume | 8 |
Issue number | 11 |
DOIs |
|
Publication status | Published - Nov 2024 |
Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial
Elias K. Mai*, Axel Nogai, Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Katja C. Weisel, Sandra Croockewit, Anna Jauch, Jens Hillengass, Marian Stevens-Kroef, Marc S. Raab, Annemiek Broijl, Gerard M.J. Bos, Peter Brossart, Paula Ypma, Christine Hanoun, Uta Bertsch, Thomas Hielscher, Hans J. Salwender, Christoph Scheid
*Corresponding author for this work
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
1
Downloads
(Pure)